No Added Benefits for Full-Defrag Ablation for AF
By HospiMedica International staff writers Posted on 30 Dec 2015 |
A stepwise approach to ablation for persistent atrial fibrillation (AF) does not offer any benefits over pulmonary vein isolation (PVI) alone, according to a new study.
Researchers at University Medical Center Hamburg-Eppendorf (UKE; Germany), University Hospital Cologne (Germany), and other institutions conducted a study involving 205 patients (151 men; mean age 61.7 years) who underwent de novo ablation for persistent AF. Subsequently, the patients were prospectively randomized to either PVI alone (78 patients), or full defragmentation ablation (75 patients), consisting of PVI, ablation of complex fractionated electrograms, and additional linear ablation lines. The remaining 52 patients were not randomized due to AF termination with the original PVI.
The primary endpoint of the study was recurrence of any atrial tachycardia (AT) after a blanking period of three months. The results showed that during the entire study, 241 ablations were performed. At 12 months, the incidence of AT was similar between recipients of PVI alone and those who underwent full defragmentation (8.2% versus 8.5%, respectively). Arrhythmia-free survival rates were also similar between groups, at 63.9% with PVI only and 57.7% with full defragmentation.
The researchers also found, conversely, that despite the fact that the rate of major complications did not differ materially between groups, the full defragmentation arm suffered a 23.3% incidence of pericardial effusion with symptoms of pericarditis, compared with a much lower 5.3% incidence in their single-procedure counterparts. The study was published on December 22, 2015, in the Journal of the American College of Cardiology.
“Pulmonary vein isolation should be the initial strategy in patients with persistent AF undergoing catheter ablation, because more extensive ablation is associated with longer procedure duration, fluoroscopy, and radiofrequency exposure, without better rhythm control outcomes,” concluded lead author Julia Vogler, MD, of University Heart Center Hamburg, and colleagues. She added, however, that “pulmonary vein isolation alone appears to be insufficient for treating persistent AF, with disappointing long-term results.”
PVI is a catheter ablation technique developed to prevent focal triggers in the pulmonary veins from initiating episodes of AF. Although the procedure initially involved focal ablation with a catheter directly in the pulmonary veins, isolating the pulmonary veins by applying ablation energy at their junction with the left atrium is more effective. The PVI procedure is most suitable for patients whose recurring symptomatic episodes of AF have not been suppressed by anti-arrhythmic drugs, or who do not wish to take long-term anti-arrhythmic or anticoagulation medications.
Related Links:
University Medical Center Hamburg-Eppendorf
University Hospital Cologne
Researchers at University Medical Center Hamburg-Eppendorf (UKE; Germany), University Hospital Cologne (Germany), and other institutions conducted a study involving 205 patients (151 men; mean age 61.7 years) who underwent de novo ablation for persistent AF. Subsequently, the patients were prospectively randomized to either PVI alone (78 patients), or full defragmentation ablation (75 patients), consisting of PVI, ablation of complex fractionated electrograms, and additional linear ablation lines. The remaining 52 patients were not randomized due to AF termination with the original PVI.
The primary endpoint of the study was recurrence of any atrial tachycardia (AT) after a blanking period of three months. The results showed that during the entire study, 241 ablations were performed. At 12 months, the incidence of AT was similar between recipients of PVI alone and those who underwent full defragmentation (8.2% versus 8.5%, respectively). Arrhythmia-free survival rates were also similar between groups, at 63.9% with PVI only and 57.7% with full defragmentation.
The researchers also found, conversely, that despite the fact that the rate of major complications did not differ materially between groups, the full defragmentation arm suffered a 23.3% incidence of pericardial effusion with symptoms of pericarditis, compared with a much lower 5.3% incidence in their single-procedure counterparts. The study was published on December 22, 2015, in the Journal of the American College of Cardiology.
“Pulmonary vein isolation should be the initial strategy in patients with persistent AF undergoing catheter ablation, because more extensive ablation is associated with longer procedure duration, fluoroscopy, and radiofrequency exposure, without better rhythm control outcomes,” concluded lead author Julia Vogler, MD, of University Heart Center Hamburg, and colleagues. She added, however, that “pulmonary vein isolation alone appears to be insufficient for treating persistent AF, with disappointing long-term results.”
PVI is a catheter ablation technique developed to prevent focal triggers in the pulmonary veins from initiating episodes of AF. Although the procedure initially involved focal ablation with a catheter directly in the pulmonary veins, isolating the pulmonary veins by applying ablation energy at their junction with the left atrium is more effective. The PVI procedure is most suitable for patients whose recurring symptomatic episodes of AF have not been suppressed by anti-arrhythmic drugs, or who do not wish to take long-term anti-arrhythmic or anticoagulation medications.
Related Links:
University Medical Center Hamburg-Eppendorf
University Hospital Cologne
Latest Surgical Techniques News
- Miniaturized Implantable Multi-Sensors Device to Monitor Vessels Health
- Tiny Robots Made Out Of Carbon Could Conduct Colonoscopy, Pelvic Exam or Blood Test
- Miniaturized Ultrasonic Scalpel Enables Faster and Safer Robotic-Assisted Surgery
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery